2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetonitrile, 95.0%, 5g

2-Pyrrolidin-1-yl-benzaldehyde, 95.0%, 10g

(R)-3-((2S,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol, 95+%, 50mg

2-(Benzo[d][1,3]dioxol-5-yl)ethene-1,1,2-tricarbonitrile, 95.0%, 1g

Methyl (S)-2-amino-3-((S)-2-oxopiperidin-3-yl)propanoate hydrochloride, 97%, 100mg

(S)-3-Amino-3-(naphthalen-1-yl)propanoic acid, 95.0%, 100mg

ETHYL 2-CYANO-2-(3,5-DIMETHOXYPHENYL)ACETATE, 95.0%, 100mg

3-(BENZYLOXY)-4-HYDROXYBENZALDEHYDE, 95.0%, 1g

Acide palmitique, minimum 98 %, le plus pur, 500 g, emballage plastique.

1-(Bicyclo[2.2.2]octan-2-yl)ethanone, 95.0%, 100mg

6-chloro-N-(2-morpholin-4-ylethyl)-1,3-benzothiazol-2-amine, 95.0%, 500mg

2,6-Dibromo-3,4,5-trimethylaniline, 97%, 250mg

Methyl 1H-pyrrole-3-carboxylate, 95.0%, 100g